Becton Dickinson and Company (BDX)

74.73 +0.32  +0.43%  May 24, 5:20PM Go Pro
Watch this stock
View Full Chart BDX Price Chart

Key Stats

Market Cap 15.70B
Revenue Growth 3.58%
Profit Margin 14.62%
Earnings Yield 7.33%
Dividend Yield 2.39%
Earnings Per Share TTM 5.48
PE Ratio 13.64
Price / Sales Ratio 1.977
52 Week High 89.75
52 Week Low 69.59
Beta 0.5727
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 22 1 Great Dividend to Buy Today Fool
May 22 Becton Dickinson (BDX) CEO Forlenza Assumes Role of Chairman Street Insider
May 22 Becton, Dickinson & Co. (BDX) Declares $0.45 Quarterly Dividend; 2.4% Yield Street Insider
May 21 The Easy Way to Invest in Companies Doing Good Fool
May 18 Top-Ranked Becton, Dickinson and Co. Getting Very Oversold
May 18 Covidien Launches HALO90 ULTRA
May 18 Covidien Launches HALO90 ULTRA - Analyst Blog Zacks
May 18 1 Great Dividend You Can Buy Right Now Fool
May 18 Dr. Robin Smith Explaining NeoStem: A True Value Play
May 16 Covidien Completes Acquisition
May 15 $BDX looking good for high prices.. No position yet. by vjtweet
May 08 Avg put/call ratio of $SPX components is 1.87. Charts of those with p/c ratio >5: $PLD $R $IVZ $SEE $BDX $TAP http://stks.co/3jNP by Attitrade
May 07 6 Healthcare Dividend Stocks For A Healthy Portfolio ($BDX, $MSA, $MDT, $OMI, $ABT, $JNJ) by iVestSyndicate
May 07 Listen to $BDX BD at Deutsche Bank AG Health Care Conference - live at 10:00 AM, ondemand after - http://stks.co/3hQ8 by earningscast
May 03 $BDX filed latest Quarterly Report http://stks.co/3ehT by MarketBrief

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Medical Instruments & Supplies

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Becton Dickinson and Company is down 11.92% over the last year vs S&P 500 Total Return up 2.33%, Baxter International down 9.87%, and C. R. Bard down 8.71%.

  • BDX Total Returns
  • ^SPXTR Total Returns
  • BAX Total Returns
  • BCR Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring BDX

Did Becton Dickinson and Company make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

BDX Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
BDX 74.73 +0.32 +0.43% 15.63B
BCSI 25.82 +0.00 +0.00% 1.105B
BCS 11.66 +0.01 +0.09% 36.71B
BCO 23.54 +0.09 +0.38% 1.100B
BCE 39.33 -0.63 -1.58% 30.99B
BBOX 22.04 -0.13 -0.59% 387.53M
BBH 45.88 +0.32 +0.70%
BBD 14.01 +0.02 +0.14% 26.75B
BBBY 72.54 +1.53 +2.15% 17.13B
BAGL 16.71 -0.01 -0.06% 282.23M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close